BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33704440)

  • 1. CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders.
    El Ghaleb Y; Schneeberger PE; Fernández-Quintero ML; Geisler SM; Pelizzari S; Polstra AM; van Hagen JM; Denecke J; Campiglio M; Liedl KR; Stevens CA; Person RE; Rentas S; Marsh ED; Conlin LK; Tuluc P; Kutsche K; Flucher BE
    Brain; 2021 Aug; 144(7):2092-2106. PubMed ID: 33704440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca
    El Ghaleb Y; Flucher BE
    Handb Exp Pharmacol; 2023; 279():263-288. PubMed ID: 36592228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional impact of alternative splicing of human T-type Cav3.3 calcium channels.
    Murbartián J; Arias JM; Perez-Reyes E
    J Neurophysiol; 2004 Dec; 92(6):3399-407. PubMed ID: 15254077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene.
    Chemin J; Siquier-Pernet K; Nicouleau M; Barcia G; Ahmad A; Medina-Cano D; Hanein S; Altin N; Hubert L; Bole-Feysot C; Fourage C; Nitschké P; Thevenon J; Rio M; Blanc P; Vidal C; Bahi-Buisson N; Desguerre I; Munnich A; Lyonnet S; Boddaert N; Fassi E; Shinawi M; Zimmerman H; Amiel J; Faivre L; Colleaux L; Lory P; Cantagrel V
    Brain; 2018 Jul; 141(7):1998-2013. PubMed ID: 29878067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired chromaffin cell excitability and exocytosis in autistic Timothy syndrome TS2-neo mouse rescued by L-type calcium channel blockers.
    Calorio C; Gavello D; Guarina L; Salio C; Sassoè-Pognetto M; Riganti C; Bianchi FT; Hofer NT; Tuluc P; Obermair GJ; Defilippi P; Balzac F; Turco E; Bett GC; Rasmusson RL; Carbone E
    J Physiol; 2019 Mar; 597(6):1705-1733. PubMed ID: 30629744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heantos-4, a natural plant extract used in the treatment of drug addiction, modulates T-type calcium channels and thalamocortical burst-firing.
    Cain SM; Ahn S; Garcia E; Zhang Y; Waheed Z; Tyson JR; Yang Y; Van Sung T; Phillips AG; Snutch TP
    Mol Brain; 2016 Dec; 9(1):94. PubMed ID: 27919294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysing an allelic series of rare missense variants of CACNA1I in a Swedish schizophrenia cohort.
    Baez-Nieto D; Allen A; Akers-Campbell S; Yang L; Budnik N; Pupo A; Shin YC; Genovese G; Liao M; Pérez-Palma E; Heyne H; Lal D; Lipscombe D; Pan JQ
    Brain; 2022 Jun; 145(5):1839-1853. PubMed ID: 34919654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical classification of a
    Hofer NT; Tuluc P; Ortner NJ; Nikonishyna YV; Fernándes-Quintero ML; Liedl KR; Flucher BE; Cox H; Striessnig J
    Mol Autism; 2020; 11(1):4. PubMed ID: 31921405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA
    Cain SM; Garcia E; Waheed Z; Jones KL; Bushell TJ; Snutch TP
    Channels (Austin); 2017 Nov; 11(6):574-586. PubMed ID: 28742985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutation in Ca
    Tyagi S; Bendrick TR; Filipova D; Papadopoulos S; Bannister RA
    J Gen Physiol; 2019 Jun; 151(6):850-859. PubMed ID: 31015257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low voltage activation of KCa1.1 current by Cav3-KCa1.1 complexes.
    Rehak R; Bartoletti TM; Engbers JD; Berecki G; Turner RW; Zamponi GW
    PLoS One; 2013; 8(4):e61844. PubMed ID: 23626738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long QT syndrome caveolin-3 mutations differentially modulate K
    Tyan L; Foell JD; Vincent KP; Woon MT; Mesquitta WT; Lang D; Best JM; Ackerman MJ; McCulloch AD; Glukhov AV; Balijepalli RC; Kamp TJ
    J Physiol; 2019 Mar; 597(6):1531-1551. PubMed ID: 30588629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo SCN8A and inherited rare CACNA1H variants associated with severe developmental and epileptic encephalopathy.
    Stringer RN; Jurkovicova-Tarabova B; Souza IA; Ibrahim J; Vacik T; Fathalla WM; Hertecant J; Zamponi GW; Lacinova L; Weiss N
    Mol Brain; 2021 Aug; 14(1):126. PubMed ID: 34399820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the gating brake in the I-II loop of CaV3 T-type calcium channels.
    Perez-Reyes E
    Channels (Austin); 2010; 4(6):453-8. PubMed ID: 21099341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in KCNK4 that Affect Gating Cause a Recognizable Neurodevelopmental Syndrome.
    Bauer CK; Calligari P; Radio FC; Caputo V; Dentici ML; Falah N; High F; Pantaleoni F; Barresi S; Ciolfi A; Pizzi S; Bruselles A; Person R; Richards S; Cho MT; Claps Sepulveda DJ; Pro S; Battini R; Zampino G; Digilio MC; Bocchinfuso G; Dallapiccola B; Stella L; Tartaglia M
    Am J Hum Genet; 2018 Oct; 103(4):621-630. PubMed ID: 30290154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons.
    Zhang Y; Mori M; Burgess DL; Noebels JL
    J Neurosci; 2002 Aug; 22(15):6362-71. PubMed ID: 12151514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal Cav3 channelopathies: recent progress and perspectives.
    Lory P; Nicole S; Monteil A
    Pflugers Arch; 2020 Jul; 472(7):831-844. PubMed ID: 32638069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy.
    Pinggera A; Mackenroth L; Rump A; Schallner J; Beleggia F; Wollnik B; Striessnig J
    Hum Mol Genet; 2017 Aug; 26(15):2923-2932. PubMed ID: 28472301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural determinants of voltage-gating properties in calcium channels.
    Fernández-Quintero ML; El Ghaleb Y; Tuluc P; Campiglio M; Liedl KR; Flucher BE
    Elife; 2021 Mar; 10():. PubMed ID: 33783354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mono-allelic KCNB2 variants lead to a neurodevelopmental syndrome caused by altered channel inactivation.
    Bhat S; Rousseau J; Michaud C; Lourenço CM; Stoler JM; Louie RJ; Clarkson LK; Lichty A; Koboldt DC; Reshmi SC; Sisodiya SM; Hoytema van Konijnenburg EMM; Koop K; van Hasselt PM; Démurger F; Dubourg C; Sullivan BR; Hughes SS; Thiffault I; Tremblay ES; Accogli A; Srour M; Blunck R; Campeau PM
    Am J Hum Genet; 2024 Apr; 111(4):761-777. PubMed ID: 38503299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.